Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry

⁃ Subjects with asymptomatic, symptomatic, or ruptured aortic aneurysms

⁃ Subject ≥ 18 years old

⁃ Subject has provided written informed consent, either before or less than or equal to 30 calendar days after the index procedure

⁃ Subject is willing and able to comply with standard of care followup evaluations

⁃ Subject has a previously implanted endograft or will be undergoing repair, with one of the following aortic aneurysm endograft devices:

∙ Cook Zenith or Cook Zenith TX2

‣ Gore Excluder or TAG

‣ Medtronic AneuRx

‣ Medtronic Talent

‣ Medtronic Endurant or Valiant

‣ Any additional third party AAA endograft device that is commercially available and listed as compatible with Heli-FX™ in the IFU

⁃ Subject's iliac/femoral access is compatible with:

∙ a 16 French sheath (abdominal subjects)

‣ 18 French sheath (thoracic subjects)

‣ Selected 16 or 18 French sheath, as applicable to the device selected for use (advanced disease subjects)

⁃ Subject has a previously implanted endograft that has migrated or has a Type I endoleak within the aorta or will undergo implantation of an endograft that in the opinion of the investigator will be at increased risk of such complications

• Subjects with asymptomatic or symptomatic abdominal aortic aneurysms that will receive the Heli-FX™ in conjunction with the Endurant II/IIs endograft as part of their planned EVAR treatment

• Subject ≥ 18 years old

• Subject has provided written informed consent, either before or less than or equal to 30 calendar days after the index procedure

• Subject is willing and able to comply with standard of care followup evaluations

• Subject will be undergoing AAA repair with the bifurcated main body Endurant II/IIs stent graft in conjunction with Heli-FX™ with a proximal neck length of ≥ 4mm to \< 10mm and treated in accordance with the Endurant II/IIs and Heli-FX™ IFUs

• Subject's iliac/femoral access is compatible with a 16 French sheath